Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study
Titel:
Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study
Auteur:
Li, Daneng McCall, Linda M. Hahn, Olwen M. Hudis, Clifford A. Cohen, Harvey J. Muss, Hyman B. Jatoi, Aminah Lafky, Jacqueline M. Ballman, Karla V. Winer, Eric P. Tripathy, Debu Schneider, Bryan Barry, William Dickler, Maura N. Hurria, Arti